awacke1/LOINC-Clinical-Terminology · Datasets at Hugging Face

LOINC_NUM stringlengths 3 8	COMPONENT stringlengths 2 246	PROPERTY stringlengths 1 29	TIME_ASPCT stringlengths 1 15	SYSTEM stringlengths 1 106	SCALE_TYP stringclasses 10 values	METHOD_TYP stringlengths 1 57 ⌀	CLASS stringlengths 2 24	CLASSTYPE int64 1 4	LONG_COMMON_NAME stringlengths 3 254	SHORTNAME stringlengths 2 51 ⌀	EXTERNAL_COPYRIGHT_NOTICE stringlengths 39 2.6k ⌀	STATUS stringclasses 4 values	VersionFirstReleased stringlengths 1 7	VersionLastChanged stringlengths 1 5
92614-7	PROMIS parent proxy short form - anxiety 8a - version 2.0 raw score	Score	7D	^Patient	Qn	PROMIS.PARENTPROXY	SURVEY.PROMIS	4	PROMIS parent proxy short form - anxiety 8a - version 2.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92615-4	PROMIS parent proxy short form - fatigue 10a - version 2.0 raw score	Score	7D	^Patient	Qn	PROMIS.PARENTPROXY	SURVEY.PROMIS	4	PROMIS parent proxy short form - fatigue 10a - version 2.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92616-2	PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92617-0	PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92618-8	PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
9261-9	Fluid output.total	VRat	12H	^Patient	Qn	null	IO_OUT.TIMED.MOLE	2	Fluid output total 12 hour	Fluid output total 12h	null	ACTIVE	1.0i	2.48
92619-6	PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92620-4	PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92621-2	PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92622-0	PROMIS short form - self-efficacy for managing emotions 8a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - self-efficacy for managing emotions 8a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92623-8	PROMIS short form - self-efficacy for managing emotions 4a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - self-efficacy for managing emotions 4a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92624-6	PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92625-3	PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92626-1	PROMIS short form - smoking - social motivations for all smokers 4a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - smoking - social motivations for all smokers 4a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
9262-7	Fluid output.total	VRat	24H	^Patient	Qn	null	IO_OUT.TIMED.MOLE	2	Fluid output total 24 hour	Fluid output total 24h	null	ACTIVE	1.0i	2.48
92627-9	PROMIS short form - smoking - nicotine dependence for all smokers 8a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - smoking - nicotine dependence for all smokers 8a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92628-7	PROMIS short form - smoking - nicotine dependence for all smokers 4a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - smoking - nicotine dependence for all smokers 4a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92629-5	PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92630-3	PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92631-1	PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92632-9	PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92633-7	PROMIS short form - upper extremity 7a - version 2.0 raw score	Score	Pt	^Patient	Qn	PROMIS	SURVEY.PROMIS	4	PROMIS short form - upper extremity 7a - version 2.0 raw score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.66	2.66
92634-5	Address type	Type	Pt	^Patient	Nom	null	ADMIN.PATIENT	2	Address type	Addr type	null	ACTIVE	2.66	2.66
9263-5	Fluid output route	Type	Pt	*	Nom	null	IO_OUT.ATOM	2	Fluid output route	Fluid output route	null	ACTIVE	1.0i	2.29
92635-2	Leukocytes	NCnc	Pt	Bld.buffy coat	Qn	null	HEM/BC	1	Leukocytes [#/volume] in Buffy Coat	WBC # Buffy Coat	null	ACTIVE	2.66	2.66
92636-0	APOL1 inferred genotype	Prid	Pt	Plas^Donor	Nom	null	MOLPATH	1	APOL1 inferred genotype [Identifier] in Plasma from Donor	APOL1 inferred Gentyp Plas Donr	null	ACTIVE	2.66	2.72
92637-8	traZODone	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	traZODone [Mass/volume] in Urine by Confirmatory method	traZODone Ur Cfm-mCnc	null	ACTIVE	2.66	2.66
92638-6	Sertraline	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Sertraline [Mass/volume] in Urine by Confirmatory method	Sertraline Ur Cfm-mCnc	null	ACTIVE	2.66	2.66
92639-4	O-nortramadol	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	O-nortramadol [Mass/volume] in Urine by Confirmatory method	O-nortramadol Ur Cfm-mCnc	null	ACTIVE	2.66	2.66
92640-2	M-chlorophenylpiperazine	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	M-chlorophenylpiperazine [Mass/volume] in Urine by Confirmatory method	m-CPP Ur Cfm-mCnc	null	ACTIVE	2.66	2.66
92641-0	diphenhydrAMINE	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	diphenhydrAMINE [Mass/volume] in Urine by Confirmatory method	Diphenhy Ur Cfm-mCnc	null	ACTIVE	2.66	2.66
92642-8	Dextromethorphan	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Dextromethorphan [Mass/volume] in Urine by Confirmatory method	D-methorphan Ur Cfm-mCnc	null	ACTIVE	2.66	2.66
9264-3	Apache II score	Score	Pt	^Patient	Ord	null	FUNCTION	2	Apache II score	Apache II score	null	ACTIVE	1.0i	2.5
92643-6	Cotinine	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Cotinine [Mass/volume] in Urine by Confirmatory method	Cotinine Ur Cfm-mCnc	null	ACTIVE	2.66	2.66
92644-4	Phentermine	MCnc	Pt	Saliva	Qn	Confirm	DRUG/TOX	1	Phentermine [Mass/volume] in Saliva (oral fluid) by Confirmatory method	Phentermine Sal Cfm-mCnc	null	ACTIVE	2.66	2.66
92645-1	Citalopram	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	Citalopram [Presence] in Urine by Confirmatory method	Citalopram Ur Ql Cfm	null	ACTIVE	2.66	2.67
92646-9	Dextromethorphan	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	Dextromethorphan [Presence] in Urine by Confirmatory method	D-methorphan Ur Ql Cfm	null	ACTIVE	2.66	2.67
92647-7	diphenhydrAMINE	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	diphenhydrAMINE [Presence] in Urine by Confirmatory method	Diphenhy Ur Ql Cfm	null	ACTIVE	2.66	2.67
92648-5	Gabapentin	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	Gabapentin [Presence] in Urine by Confirmatory method	Gabapentin Ur Ql Cfm	null	ACTIVE	2.66	2.73
92649-3	Naloxone	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	Naloxone [Presence] in Urine by Confirmatory method	Naloxone Ur Ql Cfm	null	ACTIVE	2.66	2.73
9265-0	Apache III score	Score	Pt	^Patient	Ord	null	FUNCTION	2	Apache III score	Apache III score	null	ACTIVE	1.0i	2.5
92650-1	PARoxetine	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	PARoxetine [Presence] in Urine by Confirmatory method	PARoxetine Ur Ql Cfm	null	ACTIVE	2.66	2.67
92651-9	Pregabalin	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	Pregabalin [Presence] in Urine by Confirmatory method	Pregabalin Ur Ql Cfm	null	ACTIVE	2.66	2.73
92652-7	Sertraline	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	Sertraline [Presence] in Urine by Confirmatory method	Sertraline Ur Ql Cfm	null	ACTIVE	2.66	2.67
92653-5	traZODone	PrThr	Pt	Urine	Ord	Confirm	DRUG/TOX	1	traZODone [Presence] in Urine by Confirmatory method	traZODone Ur Ql Cfm	null	ACTIVE	2.66	2.67
92654-3	9-hydroxyrisperidone	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	9-Hydroxyrisperidone [Mass/volume] in Urine by Confirmatory method	9OH-risperidone Ur Cfm-mCnc	null	ACTIVE	2.66	2.66
92655-0	Age diabetes-related problem occurred	Time	Pt	^Family member	Qn	null	H&P.HX	2	Age diabetes-related problem occurred for Family member	Diabetes-related problem age Fam Mem	null	ACTIVE	2.66	2.66
92656-8	Number of menstrual periods per Y	NRat	Pt	^Patient	Qn	null	H&P.HX	2	Number of menstrual periods per year	# menstrual periods per Y	null	ACTIVE	2.66	2.66
92657-6	Age when first fed formula	Time	Pt	^Patient	Qn	null	H&P.HX	2	Age when first fed formula	Age first fed formula	null	ACTIVE	2.66	2.66
92658-4	Had both ovaries removed	Find	Pt	^Patient	Ord	null	H&P.HX	2	Had both ovaries removed	Both ovaries removed	null	ACTIVE	2.66	2.66
92659-2	Age when stopped smoking cigarettes completely	Time	Pt	^Patient	Qn	null	H&P.HX	2	Age when stopped smoking cigarettes completely	Age stopped smoking cigarettes	null	ACTIVE	2.66	2.66
926-6	Blood product.other given	Vol	Pt	Dose	Qn	null	BLDBK	1	Blood product.other given [Volume]	Other Bld Prod Gvn Vol Dose	null	ACTIVE	1.0	2.73
92660-0	Time range until next menstrual period	Time	Pt	^Patient	Ord	null	OBGYN	2	Time range until next menstrual period	Tme rnge til Nxt Menst	null	ACTIVE	2.66	2.66
92661-8	Age when first fed something other than breast milk or formula	Time	Pt	^Patient	Qn	null	H&P.HX	2	Age when first fed something other than breast milk or formula	Age 1st fed other than brst milk or form	null	ACTIVE	2.66	2.66
92662-6	Current age or age at death	Time	Pt	^Family member	Qn	null	H&P.HX	2	Current age or age at death of Family member	Current age or death age Fam Mem	null	ACTIVE	2.66	2.66
92663-4	Problem related to diabetes	Find	Pt	^Family member	Ord	null	H&P.HX	2	Problem related to diabetes Family member	Diabetes problem Fam Mem	null	ACTIVE	2.66	2.66
92664-2	Power of attorney+Living will	Find	Pt	{Setting}	Doc	Patient	DOC.ONTOLOGY	2	Power of attorney and Living will	Patient POA+Living will	null	ACTIVE	2.66	2.68
92665-9	Growth and differentiation factor 15	MCnc	Pt	Ser/Plas	Qn	IA	CHEM	1	Growth and differentiation factor 15 [Mass/volume] in Serum or Plasma by Immunoassay	GDF-15 SerPl IA-mCnc	null	ACTIVE	2.66	2.66
92666-7	Growth hormone & glucose post cloNIDine stimulation panel	-	Pt	Ser/Plas	Qn	null	PANEL.CHAL	1	Growth hormone and glucose post cloNIDine stimulation panel - Serum or Plasma	GH + glucose p cloNIDine stim pnl SerPl	null	ACTIVE	2.66	2.66
92667-5	Glucose^30M post dose cloNIDine	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose cloNIDine	Glucose 30M p CLN SerPl-mCnc	null	ACTIVE	2.66	2.66
9266-8	Acute physiology score	Score	Pt	^Patient	Ord	null	FUNCTION	2	Acute physiology score	APS score	null	ACTIVE	1.0i	2.71
92668-3	Glucose^1H post dose cloNIDine	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Glucose [Mass/volume] in Serum or Plasma --1 hour post dose cloNIDine	Glucose 1h p CLN SerPl-mCnc	null	ACTIVE	2.66	2.66
92669-1	Glucose^1.5H post dose cloNIDine	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose cloNIDine	Glucose 1.5h p CLN SerPl-mCnc	null	ACTIVE	2.66	2.66
92670-9	Glucose^2H post dose cloNIDine	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Glucose [Mass/volume] in Serum or Plasma --2 hours post dose cloNIDine	Glucose 2h p CLN SerPl-mCnc	null	ACTIVE	2.66	2.66
92671-7	Basement membrane zone BP180 & BP230 Ab.IgG panel	-	Pt	Ser/Plas	Qn	null	PANEL.CHEM	1	Basement membrane zone BP180 and BP230 IgG panel - Serum or Plasma	BMZ BP180 + BP230 IgG Pnl SerPl	null	ACTIVE	2.66	2.66
92672-5	Hydroxyglutarates & Glutarate & Ethylmalonate & Methylsuccinate panel	-	Pt	Bld.dot	Qn	null	PANEL.CHEM	1	Hydroxyglutarates and glutarate and ethylmalonate and methylsuccinate panel - DBS	Gluts + Eth + Meth Pnl DBS	null	ACTIVE	2.66	2.66
92673-3	Hydroxyglutarates & Glutarate & Ethylmalonate & Methylsuccinate panel	-	Pt	Ser/Plas	Qn	null	PANEL.CHEM	1	Hydroxyglutarates and glutarate and ethylmalonate and methylsuccinate panel - Serum or Plasma	Gluts + Eth + Meth Pnl SerPl	null	ACTIVE	2.66	2.66
92674-1	CSF3R gene exons 14 & 17 targeted mutation analysis	Find	Pt	Bld/Tiss	Doc	Molgen	MOLPATH.MUT	1	CSF3R gene exons 14 and 17 targeted mutation analysis in Blood or Tissue by Molecular genetics method	CSF3R gene exon 14+17 Mut Anl Bld/T	null	ACTIVE	2.66	2.66
92675-8	MSH2 gene deletion+duplication & full mutation analysis	Find	Pt	Bld/Tiss	Doc	Molgen	MOLPATH	1	MSH2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method	MSH2 gene Del+Dup + Full Mut Anl Bld/T	null	ACTIVE	2.66	2.66
9267-6	Glasgow coma score.eye opening	Fcn	Pt	^Patient	Ord	null	FUNCTION	2	Glasgow coma score eye opening	GCS eye	null	ACTIVE	1.0i	2.73
92676-6	MLH1 gene deletion+duplication & full mutation analysis	Find	Pt	Bld/Tiss	Doc	Molgen	MOLPATH	1	MLH1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method	MLH1 gene Del+Dup + Full Mut Anl Bld/T	null	ACTIVE	2.66	2.66
92677-4	Views GE 4	Find	Pt	Pelvis & Lower extremity>Hip	Doc	XR	RAD	2	XR Pelvis and Hip GE 4 Views	XR Pelvis and Hip GE 4V	null	ACTIVE	2.66	2.67
92678-2	Multisection	Find	Pt	Chest>Lung	Doc	US.elastography	RAD	2	US.elastography Lung	USE Lung	null	ACTIVE	2.66	2.72
92679-0	Multisection for lesion	Find	Pt	Chest>Lung	Doc	US.elastography	RAD	2	US.elastography Lung for lesion	USE Lung for lesion	null	ACTIVE	2.66	2.72
92680-8	Multisection additional for lesion	Find	Pt	Chest>Lung	Doc	US.elastography	RAD	2	US.elastography Lung additional for lesion	USE Lung lesion addl	null	ACTIVE	2.66	2.72
92681-6	Guidance for dilation of existing nephrostomy tract	Find	Pt	Abdomen>Kidney	Doc	{Imaging modality}	RAD	2	Guidance for dilation of existing nephrostomy tract of Kidney	Guided Kidney Dilation exist nephr tract	null	TRIAL	2.66	2.67
92682-4	Guidance for dilation of existing nephrostomy tract+placement of nephrostomy tube at new site	Find	Pt	Abdomen>Kidney	Doc	{Imaging modality}	RAD	2	Guidance for dilation of existing nephrostomy tract and placement of nephrostomy tube at new site of Kidney	Guided Dil exist nephr tr+tube new site	null	TRIAL	2.66	2.67
92683-2	Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA panel	-	Pt	Genital	-	Probe.amp.tar	PANEL.MICRO	1	Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Genital specimen by NAA with probe detection	CT + NG + TV DNA Pnl Genital NAA+probe	null	ACTIVE	2.66	2.66
9268-4	Glasgow coma score.motor	Fcn	Pt	^Patient	Ord	null	FUNCTION	2	Glasgow coma score motor	GCS motor	null	ACTIVE	1.0i	2.73
92684-0	Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA panel	-	Pt	Urine	-	Probe.amp.tar	PANEL.MICRO	1	Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Urine by NAA with probe detection	CT + NG + TV DNA Pnl Ur NAA+probe	null	ACTIVE	2.66	2.66
92685-7	Trichomonas vaginalis DNA	PrThr	Pt	Urine	Ord	Probe.amp.tar	MICRO	1	Trichomonas vaginalis DNA [Presence] in Urine by NAA with probe detection	T vaginalis DNA Ur Ql NAA+probe	null	ACTIVE	2.66	2.66
92686-5	Vibrio cholerae+parahaemolyticus+vulnificus DNA	PrThr	Pt	Stool	Ord	Probe.amp.tar	MICRO	1	Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with probe detection	V chol+para+vul DNA Stl Ql NAA+probe	null	ACTIVE	2.66	2.66
92687-3	Giardia lamblia DNA	PrThr	Pt	Stool	Ord	Probe.amp.tar	MICRO	1	Giardia lamblia DNA [Presence] in Stool by NAA with probe detection	G lamblia DNA Stl Ql NAA+probe	null	ACTIVE	2.66	2.66
92688-1	Cryptosporidium parvum+hominis DNA	PrThr	Pt	Stool	Ord	Probe.amp.tar	MICRO	1	Cryptosporidium parvum+hominis DNA [Presence] in Stool by NAA with probe detection	C parvum+hominis DNA Stl Ql NAA+probe	null	ACTIVE	2.66	2.66
92689-9	Entamoeba histolytica DNA	PrThr	Pt	Stool	Ord	Probe.amp.tar	MICRO	1	Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection	E histolyt DNA Stl Ql NAA+probe	null	ACTIVE	2.66	2.66
92690-7	Adenovirus 40+41 DNA	PrThr	Pt	Stool	Ord	Probe.amp.tar	MICRO	1	Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection	AdV 40+41 DNA Stl Ql NAA+probe	null	ACTIVE	2.66	2.66
92691-5	Astrovirus RNA	PrThr	Pt	Stool	Ord	Probe.amp.tar	MICRO	1	Astrovirus RNA [Presence] in Stool by NAA with probe detection	HAstV RNA Stl Ql NAA+probe	null	ACTIVE	2.66	2.66
9269-2	Glasgow coma score.total	Fcn	Pt	^Patient	Qn	null	FUNCTION	2	Glasgow coma score total	GCS total	null	ACTIVE	1.0i	2.73
92692-3	Norovirus genogroup I+II RNA	PrThr	Pt	Stool	Ord	Probe.amp.tar	MICRO	1	Norovirus genogroup I+II RNA [Presence] in Stool by NAA with probe detection	Norovirus GI+II RNA Stl Ql NAA+probe	null	ACTIVE	2.66	2.66
92693-1	Rotavirus A RNA	PrThr	Pt	Stool	Ord	Probe.amp.tar	MICRO	1	Rotavirus A RNA [Presence] in Stool by NAA with probe detection	RVA RNA Stl Ql NAA+probe	null	ACTIVE	2.66	2.66
92694-9	Sapovirus genogroups I+II+IV+V RNA	PrThr	Pt	Stool	Ord	Probe.amp.tar	MICRO	1	Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection	Sapo I+II+IV+V RNA Stl Ql NAA+probe	null	ACTIVE	2.66	2.66
92695-6	Gastrointestinal bacterial pathogens panel	-	Pt	Stool	-	Probe.amp.tar	PANEL.MICRO	1	Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection	GI bact pathogens Pnl Stl NAA+probe	null	ACTIVE	2.66	2.7
92696-4	Gastrointestinal viral pathogens panel	-	Pt	Stool	-	Probe.amp.tar	PANEL.MICRO	1	Gastrointestinal viral pathogens panel - Stool by NAA with probe detection	GI viral pathogens Pnl Stl NAA+probe	null	ACTIVE	2.66	2.7
92697-2	Gastrointestinal parasitic pathogens panel	-	Pt	Stool	-	Probe.amp.tar	PANEL.MICRO	1	Gastrointestinal parasitic pathogens panel - Stool by NAA with probe detection	GI parasitic pathogens Pnl Stl NAA+probe	null	ACTIVE	2.66	2.7
92698-0	Gardnerella vaginalis DNA	PrThr	Pt	Vag	Ord	Probe	MICRO	1	Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe	G vaginalis DNA Vag Ql Probe	null	ACTIVE	2.66	2.66
92699-8	Candida sp DNA	PrThr	Pt	Vag	Ord	Probe	MICRO	1	Candida sp DNA [Presence] in Vaginal fluid by Probe	Candida DNA Vag Ql Probe	null	ACTIVE	2.66	2.66
92-7	Cefodizime	Susc	Pt	Isolate	OrdQn	MIC	ABXBACT	1	Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC)	Cefodizime Islt MIC	null	ACTIVE	1.0	2.19
9270-0	Glasgow coma score.verbal	Fcn	Pt	^Patient	Ord	null	FUNCTION	2	Glasgow coma score verbal	GCS verbal	null	ACTIVE	1.0i	2.27
92700-4	Trichomonas vaginalis DNA	PrThr	Pt	Vag	Ord	Probe	MICRO	1	Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe	T vaginalis DNA Vag Ql Probe	null	ACTIVE	2.66	2.66
92701-2	Staphylococcus aureus DNA	PrThr	Pt	Nose	Ord	Probe.amp.tar	MICRO	1	Staphylococcus aureus DNA [Presence] in Nose by NAA with probe detection	S aureus DNA Nose Ql NAA+probe	null	ACTIVE	2.66	2.66

92614-7

PROMIS parent proxy short form - anxiety 8a - version 2.0 raw score

Score

7D

^Patient

Qn

PROMIS.PARENTPROXY

SURVEY.PROMIS

4

PROMIS parent proxy short form - anxiety 8a - version 2.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92615-4

PROMIS parent proxy short form - fatigue 10a - version 2.0 raw score

Score

7D

^Patient

Qn

PROMIS.PARENTPROXY

SURVEY.PROMIS

4

PROMIS parent proxy short form - fatigue 10a - version 2.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92616-2

PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92617-0

PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92618-8

PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

9261-9

Fluid output.total

VRat

12H

^Patient

Qn

null

IO_OUT.TIMED.MOLE

2

Fluid output total 12 hour

Fluid output total 12h

null

ACTIVE

1.0i

2.48

92619-6

PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92620-4

PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92621-2

PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92622-0

PROMIS short form - self-efficacy for managing emotions 8a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - self-efficacy for managing emotions 8a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92623-8

PROMIS short form - self-efficacy for managing emotions 4a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - self-efficacy for managing emotions 4a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92624-6

PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92625-3

PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92626-1

PROMIS short form - smoking - social motivations for all smokers 4a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - smoking - social motivations for all smokers 4a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

9262-7

Fluid output.total

VRat

24H

^Patient

Qn

null

IO_OUT.TIMED.MOLE

2

Fluid output total 24 hour

Fluid output total 24h

null

ACTIVE

1.0i

2.48

92627-9

PROMIS short form - smoking - nicotine dependence for all smokers 8a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - smoking - nicotine dependence for all smokers 8a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92628-7

PROMIS short form - smoking - nicotine dependence for all smokers 4a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - smoking - nicotine dependence for all smokers 4a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92629-5

PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92630-3

PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92631-1

PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92632-9

PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92633-7

PROMIS short form - upper extremity 7a - version 2.0 raw score

Score

Pt

^Patient

Qn

PROMIS

SURVEY.PROMIS

4

PROMIS short form - upper extremity 7a - version 2.0 raw score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.66

92634-5

Address type

Type

Pt

^Patient

Nom

null

ADMIN.PATIENT

2

Address type

Addr type

null

ACTIVE

2.66

9263-5

Fluid output route

Type

Pt

*

Nom

null

IO_OUT.ATOM

2

Fluid output route

null

ACTIVE

1.0i

2.29

92635-2

Leukocytes

NCnc

Pt

Bld.buffy coat

Qn

null

HEM/BC

1

Leukocytes [#/volume] in Buffy Coat

WBC # Buffy Coat

null

ACTIVE

2.66

92636-0

APOL1 inferred genotype

Prid

Pt

Plas^Donor

Nom

null

MOLPATH

1

APOL1 inferred genotype [Identifier] in Plasma from Donor

APOL1 inferred Gentyp Plas Donr

null

ACTIVE

2.66

2.72

92637-8

traZODone

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

traZODone [Mass/volume] in Urine by Confirmatory method

traZODone Ur Cfm-mCnc

null

ACTIVE

2.66

92638-6

Sertraline

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Sertraline [Mass/volume] in Urine by Confirmatory method

Sertraline Ur Cfm-mCnc

null

ACTIVE

2.66

92639-4

O-nortramadol

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

O-nortramadol [Mass/volume] in Urine by Confirmatory method

O-nortramadol Ur Cfm-mCnc

null

ACTIVE

2.66

92640-2

M-chlorophenylpiperazine

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

M-chlorophenylpiperazine [Mass/volume] in Urine by Confirmatory method

m-CPP Ur Cfm-mCnc

null

ACTIVE

2.66

92641-0

diphenhydrAMINE

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

diphenhydrAMINE [Mass/volume] in Urine by Confirmatory method

Diphenhy Ur Cfm-mCnc

null

ACTIVE

2.66

92642-8

Dextromethorphan

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Dextromethorphan [Mass/volume] in Urine by Confirmatory method

D-methorphan Ur Cfm-mCnc

null

ACTIVE

2.66

9264-3

Apache II score

Score

Pt

^Patient

Ord

null

FUNCTION

2

Apache II score

null

ACTIVE

1.0i

2.5

92643-6

Cotinine

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Cotinine [Mass/volume] in Urine by Confirmatory method

Cotinine Ur Cfm-mCnc

null

ACTIVE

2.66

92644-4

Phentermine

MCnc

Pt

Saliva

Qn

Confirm

DRUG/TOX

1

Phentermine [Mass/volume] in Saliva (oral fluid) by Confirmatory method

Phentermine Sal Cfm-mCnc

null

ACTIVE

2.66

92645-1

Citalopram

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

Citalopram [Presence] in Urine by Confirmatory method

Citalopram Ur Ql Cfm

null

ACTIVE

2.66

2.67

92646-9

Dextromethorphan

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

Dextromethorphan [Presence] in Urine by Confirmatory method

D-methorphan Ur Ql Cfm

null

ACTIVE

2.66

2.67

92647-7

diphenhydrAMINE

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

diphenhydrAMINE [Presence] in Urine by Confirmatory method

Diphenhy Ur Ql Cfm

null

ACTIVE

2.66

2.67

92648-5

Gabapentin

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

Gabapentin [Presence] in Urine by Confirmatory method

Gabapentin Ur Ql Cfm

null

ACTIVE

2.66

2.73

92649-3

Naloxone

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

Naloxone [Presence] in Urine by Confirmatory method

Naloxone Ur Ql Cfm

null

ACTIVE

2.66

2.73

9265-0

Apache III score

Score

Pt

^Patient

Ord

null

FUNCTION

2

Apache III score

null

ACTIVE

1.0i

2.5

92650-1

PARoxetine

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

PARoxetine [Presence] in Urine by Confirmatory method

PARoxetine Ur Ql Cfm

null

ACTIVE

2.66

2.67

92651-9

Pregabalin

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

Pregabalin [Presence] in Urine by Confirmatory method

Pregabalin Ur Ql Cfm

null

ACTIVE

2.66

2.73

92652-7

Sertraline

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

Sertraline [Presence] in Urine by Confirmatory method

Sertraline Ur Ql Cfm

null

ACTIVE

2.66

2.67

92653-5

traZODone

PrThr

Pt

Urine

Ord

Confirm

DRUG/TOX

1

traZODone [Presence] in Urine by Confirmatory method

traZODone Ur Ql Cfm

null

ACTIVE

2.66

2.67

92654-3

9-hydroxyrisperidone

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

9-Hydroxyrisperidone [Mass/volume] in Urine by Confirmatory method

9OH-risperidone Ur Cfm-mCnc

null

ACTIVE

2.66

92655-0

Age diabetes-related problem occurred

Time

Pt

^Family member

Qn

null

H&P.HX

2

Age diabetes-related problem occurred for Family member

Diabetes-related problem age Fam Mem

null

ACTIVE

2.66

92656-8

Number of menstrual periods per Y

NRat

Pt

^Patient

Qn

null

H&P.HX

2

Number of menstrual periods per year

# menstrual periods per Y

null

ACTIVE

2.66

92657-6

Age when first fed formula

Time

Pt

^Patient

Qn

null

H&P.HX

2

Age when first fed formula

Age first fed formula

null

ACTIVE

2.66

92658-4

Had both ovaries removed

Find

Pt

^Patient

Ord

null

H&P.HX

2

Had both ovaries removed

Both ovaries removed

null

ACTIVE

2.66

92659-2

Age when stopped smoking cigarettes completely

Time

Pt

^Patient

Qn

null

H&P.HX

2

Age when stopped smoking cigarettes completely

Age stopped smoking cigarettes

null

ACTIVE

2.66

926-6

Blood product.other given

Vol

Pt

Dose

Qn

null

BLDBK

1

Blood product.other given [Volume]

Other Bld Prod Gvn Vol Dose

null

ACTIVE

1.0

2.73

92660-0

Time range until next menstrual period

Time

Pt

^Patient

Ord

null

OBGYN

2

Time range until next menstrual period

Tme rnge til Nxt Menst

null

ACTIVE

2.66

92661-8

Age when first fed something other than breast milk or formula

Time

Pt

^Patient

Qn

null

H&P.HX

2

Age when first fed something other than breast milk or formula

Age 1st fed other than brst milk or form

null

ACTIVE

2.66

92662-6

Current age or age at death

Time

Pt

^Family member

Qn

null

H&P.HX

2

Current age or age at death of Family member

Current age or death age Fam Mem

null

ACTIVE

2.66

92663-4

Problem related to diabetes

Find

Pt

^Family member

Ord

null

H&P.HX

2

Problem related to diabetes Family member

Diabetes problem Fam Mem

null

ACTIVE

2.66

92664-2

Power of attorney+Living will

Find

Pt

{Setting}

Doc

Patient

DOC.ONTOLOGY

2

Power of attorney and Living will

Patient POA+Living will

null

ACTIVE

2.66

2.68

92665-9

Growth and differentiation factor 15

MCnc

Pt

Ser/Plas

Qn

IA

CHEM

1

Growth and differentiation factor 15 [Mass/volume] in Serum or Plasma by Immunoassay

GDF-15 SerPl IA-mCnc

null

ACTIVE

2.66

92666-7

Growth hormone & glucose post cloNIDine stimulation panel

-

Pt

Ser/Plas

Qn

null

PANEL.CHAL

1

Growth hormone and glucose post cloNIDine stimulation panel - Serum or Plasma

GH + glucose p cloNIDine stim pnl SerPl

null

ACTIVE

2.66

92667-5

Glucose^30M post dose cloNIDine

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose cloNIDine

Glucose 30M p CLN SerPl-mCnc

null

ACTIVE

2.66

9266-8

Acute physiology score

Score

Pt

^Patient

Ord

null

FUNCTION

2

Acute physiology score

APS score

null

ACTIVE

1.0i

2.71

92668-3

Glucose^1H post dose cloNIDine

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Glucose [Mass/volume] in Serum or Plasma --1 hour post dose cloNIDine

Glucose 1h p CLN SerPl-mCnc

null

ACTIVE

2.66

92669-1

Glucose^1.5H post dose cloNIDine

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose cloNIDine

Glucose 1.5h p CLN SerPl-mCnc

null

ACTIVE

2.66

92670-9

Glucose^2H post dose cloNIDine

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Glucose [Mass/volume] in Serum or Plasma --2 hours post dose cloNIDine

Glucose 2h p CLN SerPl-mCnc

null

ACTIVE

2.66

92671-7

Basement membrane zone BP180 & BP230 Ab.IgG panel

-

Pt

Ser/Plas

Qn

null

PANEL.CHEM

1

Basement membrane zone BP180 and BP230 IgG panel - Serum or Plasma

BMZ BP180 + BP230 IgG Pnl SerPl

null

ACTIVE

2.66

92672-5

Hydroxyglutarates & Glutarate & Ethylmalonate & Methylsuccinate panel

-

Pt

Bld.dot

Qn

null

PANEL.CHEM

1

Hydroxyglutarates and glutarate and ethylmalonate and methylsuccinate panel - DBS

Gluts + Eth + Meth Pnl DBS

null

ACTIVE

2.66

92673-3

Hydroxyglutarates & Glutarate & Ethylmalonate & Methylsuccinate panel

-

Pt

Ser/Plas

Qn

null

PANEL.CHEM

1

Hydroxyglutarates and glutarate and ethylmalonate and methylsuccinate panel - Serum or Plasma

Gluts + Eth + Meth Pnl SerPl

null

ACTIVE

2.66

92674-1

CSF3R gene exons 14 & 17 targeted mutation analysis

Find

Pt

Bld/Tiss

Doc

Molgen

MOLPATH.MUT

1

CSF3R gene exons 14 and 17 targeted mutation analysis in Blood or Tissue by Molecular genetics method

CSF3R gene exon 14+17 Mut Anl Bld/T

null

ACTIVE

2.66

92675-8

MSH2 gene deletion+duplication & full mutation analysis

Find

Pt

Bld/Tiss

Doc

Molgen

MOLPATH

1

MSH2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method

MSH2 gene Del+Dup + Full Mut Anl Bld/T

null

ACTIVE

2.66

9267-6

Glasgow coma score.eye opening

Fcn

Pt

^Patient

Ord

null

FUNCTION

2

Glasgow coma score eye opening

GCS eye

null

ACTIVE

1.0i

2.73

92676-6

MLH1 gene deletion+duplication & full mutation analysis

Find

Pt

Bld/Tiss

Doc

Molgen

MOLPATH

1

MLH1 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method

MLH1 gene Del+Dup + Full Mut Anl Bld/T

null

ACTIVE

2.66

92677-4

Views GE 4

Find

Pt

Pelvis & Lower extremity>Hip

Doc

XR

RAD

2

XR Pelvis and Hip GE 4 Views

XR Pelvis and Hip GE 4V

null

ACTIVE

2.66

2.67

92678-2

Multisection

Find

Pt

Chest>Lung

Doc

US.elastography

RAD

2

US.elastography Lung

USE Lung

null

ACTIVE

2.66

2.72

92679-0

Multisection for lesion

Find

Pt

Chest>Lung

Doc

US.elastography

RAD

2

US.elastography Lung for lesion

USE Lung for lesion

null

ACTIVE

2.66

2.72

92680-8

Multisection additional for lesion

Find

Pt

Chest>Lung

Doc

US.elastography

RAD

2

US.elastography Lung additional for lesion

USE Lung lesion addl

null

ACTIVE

2.66

2.72

92681-6

Guidance for dilation of existing nephrostomy tract

Find

Pt

Abdomen>Kidney

Doc

{Imaging modality}

RAD

2

Guidance for dilation of existing nephrostomy tract of Kidney

Guided Kidney Dilation exist nephr tract

null

TRIAL

2.66

2.67

92682-4

Guidance for dilation of existing nephrostomy tract+placement of nephrostomy tube at new site

Find

Pt

Abdomen>Kidney

Doc

{Imaging modality}

RAD

2

Guidance for dilation of existing nephrostomy tract and placement of nephrostomy tube at new site of Kidney

Guided Dil exist nephr tr+tube new site

null

TRIAL

2.66

2.67

92683-2

Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA panel

-

Pt

Genital

-

Probe.amp.tar

PANEL.MICRO

1

Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Genital specimen by NAA with probe detection

CT + NG + TV DNA Pnl Genital NAA+probe

null

ACTIVE

2.66

9268-4

Glasgow coma score.motor

Fcn

Pt

^Patient

Ord

null

FUNCTION

2

Glasgow coma score motor

GCS motor

null

ACTIVE

1.0i

2.73

92684-0

Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA panel

-

Pt

Urine

-

Probe.amp.tar

PANEL.MICRO

1

Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA panel - Urine by NAA with probe detection

CT + NG + TV DNA Pnl Ur NAA+probe

null

ACTIVE

2.66

92685-7

Trichomonas vaginalis DNA

PrThr

Pt

Urine

Ord

Probe.amp.tar

MICRO

1

Trichomonas vaginalis DNA [Presence] in Urine by NAA with probe detection

T vaginalis DNA Ur Ql NAA+probe

null

ACTIVE

2.66

92686-5

Vibrio cholerae+parahaemolyticus+vulnificus DNA

PrThr

Pt

Stool

Ord

Probe.amp.tar

MICRO

1

Vibrio cholerae+parahaemolyticus+vulnificus DNA [Presence] in Stool by NAA with probe detection

V chol+para+vul DNA Stl Ql NAA+probe

null

ACTIVE

2.66

92687-3

Giardia lamblia DNA

PrThr

Pt

Stool

Ord

Probe.amp.tar

MICRO

1

Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

G lamblia DNA Stl Ql NAA+probe

null

ACTIVE

2.66

92688-1

Cryptosporidium parvum+hominis DNA

PrThr

Pt

Stool

Ord

Probe.amp.tar

MICRO

1

Cryptosporidium parvum+hominis DNA [Presence] in Stool by NAA with probe detection

C parvum+hominis DNA Stl Ql NAA+probe

null

ACTIVE

2.66

92689-9

Entamoeba histolytica DNA

PrThr

Pt

Stool

Ord

Probe.amp.tar

MICRO

1

Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

E histolyt DNA Stl Ql NAA+probe

null

ACTIVE

2.66

92690-7

Adenovirus 40+41 DNA

PrThr

Pt

Stool

Ord

Probe.amp.tar

MICRO

1

Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

AdV 40+41 DNA Stl Ql NAA+probe

null

ACTIVE

2.66

92691-5

Astrovirus RNA

PrThr

Pt

Stool

Ord

Probe.amp.tar

MICRO

1

Astrovirus RNA [Presence] in Stool by NAA with probe detection

HAstV RNA Stl Ql NAA+probe

null

ACTIVE

2.66

9269-2

Glasgow coma score.total

Fcn

Pt

^Patient

Qn

null

FUNCTION

2

Glasgow coma score total

GCS total

null

ACTIVE

1.0i

2.73

92692-3

Norovirus genogroup I+II RNA

PrThr

Pt

Stool

Ord

Probe.amp.tar

MICRO

1

Norovirus genogroup I+II RNA [Presence] in Stool by NAA with probe detection

Norovirus GI+II RNA Stl Ql NAA+probe

null

ACTIVE

2.66

92693-1

Rotavirus A RNA

PrThr

Pt

Stool

Ord

Probe.amp.tar

MICRO

1

Rotavirus A RNA [Presence] in Stool by NAA with probe detection

RVA RNA Stl Ql NAA+probe

null

ACTIVE

2.66

92694-9

Sapovirus genogroups I+II+IV+V RNA

PrThr

Pt

Stool

Ord

Probe.amp.tar

MICRO

1

Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

Sapo I+II+IV+V RNA Stl Ql NAA+probe

null

ACTIVE

2.66

92695-6

Gastrointestinal bacterial pathogens panel

-

Pt

Stool

-

Probe.amp.tar

PANEL.MICRO

1

Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

GI bact pathogens Pnl Stl NAA+probe

null

ACTIVE

2.66

2.7

92696-4

Gastrointestinal viral pathogens panel

-

Pt

Stool

-

Probe.amp.tar

PANEL.MICRO

1

Gastrointestinal viral pathogens panel - Stool by NAA with probe detection

GI viral pathogens Pnl Stl NAA+probe

null

ACTIVE

2.66

2.7

92697-2

Gastrointestinal parasitic pathogens panel

-

Pt

Stool

-

Probe.amp.tar

PANEL.MICRO

1

Gastrointestinal parasitic pathogens panel - Stool by NAA with probe detection

GI parasitic pathogens Pnl Stl NAA+probe

null

ACTIVE

2.66

2.7

92698-0

Gardnerella vaginalis DNA

PrThr

Pt

Vag

Ord

Probe

MICRO

1

Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe

G vaginalis DNA Vag Ql Probe

null

ACTIVE

2.66

92699-8

Candida sp DNA

PrThr

Pt

Vag

Ord

Probe

MICRO

1

Candida sp DNA [Presence] in Vaginal fluid by Probe

Candida DNA Vag Ql Probe

null

ACTIVE

2.66

92-7

Cefodizime

Susc

Pt

Isolate

OrdQn

MIC

ABXBACT

1

Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC)

Cefodizime Islt MIC

null

ACTIVE

1.0

2.19

9270-0

Glasgow coma score.verbal

Fcn

Pt

^Patient

Ord

null

FUNCTION

2

Glasgow coma score verbal

GCS verbal

null

ACTIVE

1.0i

2.27

92700-4

Trichomonas vaginalis DNA

PrThr

Pt

Vag

Ord

Probe

MICRO

1

Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe

T vaginalis DNA Vag Ql Probe

null

ACTIVE

2.66

92701-2

Staphylococcus aureus DNA

PrThr

Pt

Nose

Ord

Probe.amp.tar

MICRO

1

Staphylococcus aureus DNA [Presence] in Nose by NAA with probe detection

S aureus DNA Nose Ql NAA+probe

null

ACTIVE

2.66